Skip to content

Author

Ilya Laufer

We have 3 of 46 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

SADA-08 FUSION SURGERY FOR PATIENTS WITH METASTATIC SPINE DISEASE: IS FUSION NECESSARY?

It is concluded that instrumented stabilization without formal fusion is a reasonable and potentially preferable approach for many patients with spinal metastases, especially true in cases of limited life expectancy and lower instability scores.

Andrew A. Hardigan, F. Landriel, F. Cofano et al. · 0 citations
Open access Aug 2026

SADA-13 TOWARD CONSENSUS: DEFINING OPTIMAL SURGICAL OUTCOMES IN METASTATIC SPINE DISEASE

This is the first study defining a composite measure outcome in oncologic surgery for spinal metastases derived from an international group of surgeons and oncologists who treat patients for MSD and the OSCO-M will be useful for defining clinical success in patients undergoing treatment for MSD.

Andrew A. Hardigan, R. de la Garza Ramos, Michael H. Weber et al. · 0 citations
Review Open access Aug 2026

SUPC-05 FRAILTY AND SARCOPENIA IN SPINAL ONCOLOGY: A SYSTEMATIC REVIEW

Frailty and sarcopenia are common in the MSD population and multidimensional measurements of health that must be carefully considered with regard to treatment decision making, however, this review reinforces the lack of readily available tool to quantify both conditions and their effect on outcomes.

Eli Johnson, Mark A. Maclean, Antoinette J. Charles et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.